| 2026-03-12 |
详情>>
股本变动：
变动后总股本1388.68万股
变动原因 ▼▲
- 原因：
- From October 31, 2025 to January 31, 2026
Issuance of common stock on exercise of stock options
|
| 2026-03-12 |
详情>>
业绩披露：
2026年三季报(累计)每股收益-0.04美元,归母净利润-50.8万美元,同比去年增长-107.77%
|
| 2026-03-12 |
财报披露：
美东时间 2026-03-12 盘后发布财报
|
| 2025-12-15 |
详情>>
业绩披露：
2026年中报每股收益-0.01美元,归母净利润-16.9万美元,同比去年增长-108.28%
|
| 2025-10-30 |
详情>>
内部人交易：
ACKERMAN JOEL股份增加94405.00股
|
| 2025-09-15 |
详情>>
业绩披露：
2026年一季报每股收益-0.03美元,归母净利润-43.6万美元,同比去年增长-133.21%
|
| 2025-08-22 |
股东大会：
将于2025-10-16召开股东大会
会议内容 ▼▲
- 1.Elect the seven Board of Director nominees named in the accompanying Proxy Statement to the Board of Directors for the ensuing year and until his successor has been elected and qualified, or until his earlier death, resignation or removal;
2.Ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2026;
3.Approve a non-binding advisory resolution relating to the compensation of our named executive officers;
4.Transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2025-07-24 |
复牌提示：
2025-07-24 09:30:48 停牌，复牌日期 2025-07-24 09:35:48
|
| 2025-07-23 |
详情>>
业绩披露：
2025年年报每股收益0.34美元,归母净利润470.10万美元,同比去年增长164.61%
|
| 2025-03-17 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.48美元,归母净利润653.60万美元,同比去年增长191.20%
|
| 2024-12-16 |
详情>>
业绩披露：
2025年中报每股收益0.15美元,归母净利润204.10万美元,同比去年增长144.02%
|
| 2024-09-13 |
详情>>
业绩披露：
2025年一季报每股收益0.10美元,归母净利润131.30万美元,同比去年增长151.17%
|
| 2024-08-27 |
股东大会：
将于2024-10-14召开股东大会
会议内容 ▼▲
- 1.Elect the seven Board of Director nominees named in the accompanying Proxy Statement to the Board of Directors for the ensuing year and until his successor has been elected and qualified, or until his earlier death, resignation or removal;
2.Ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2025;
3.Approve a non-binding advisory resolution relating to the compensation of our named executive officers;
4.Transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2024-07-19 |
详情>>
业绩披露：
2024年年报每股收益-0.54美元,归母净利润-727.6万美元,同比去年增长-36.38%
|
| 2024-03-15 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.53美元,归母净利润-716.7万美元,同比去年增长-158.36%
|
| 2023-12-13 |
详情>>
业绩披露：
2024年中报每股收益-0.34美元,归母净利润-463.7万美元,同比去年增长-1284.18%
|
| 2023-08-28 |
股东大会：
将于2023-10-19召开股东大会
会议内容 ▼▲
- 1.Elect the seven Board of Director nominees named in the accompanying Proxy Statement to the Board of Directors for the ensuing year and until his successor has been elected and qualified, or until his earlier death, resignation or removal;
2.Ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2024;
3.Approve a non-binding advisory resolution relating to the compensation of our named executive officers;
4.Transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2022-08-29 |
股东大会：
将于2022-10-20召开股东大会
会议内容 ▼▲
- 1.Elect the seven Board of Director nominees named in the accompanying Proxy Statement to the Board of Directors for the ensuing year and until his successor has been elected and qualified, or until his earlier death, resignation or removal;
2.Ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2023;
3.Approve a non-binding advisory resolution relating to the compensation of our named executive officers;
4.Transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-30 |
股东大会：
将于2021-10-20召开股东大会
会议内容 ▼▲
- 1.Elect the seven Board of Director nominees named in the accompanying Proxy Statement to the Board of Directors for the ensuing year and until his successor has been elected and qualified, or until his earlier death, resignation or removal;
2.Ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2022;
3.Approve a non-binding advisory resolution relating to the compensation of our named executive officers;
4.Approve the 2021 Equity Incentive Plan (the "Incentive Plan");
5.Transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2020-09-11 |
股东大会：
将于2020-10-13召开股东大会
会议内容 ▼▲
- 1.Elect the seven Board of Director nominees named in the accompanying Proxy Statement to the Board of Directors for the ensuing year and until his successor has been elected and qualified, or until his earlier death, resignation or removal;
2.Ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2021;
3.Approve a non-binding advisory resolution relating to the compensation of our named executive officers;
4.Approve a non-binding advisory resolution on the frequency of stockholder votes (every one, two or three years) relating to the compensation of our named executive officers;
5.Transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2020-09-11 |
股东大会：
将于2020-10-21召开股东大会
会议内容 ▼▲
- 1.Elect the seven Board of Director nominees named in the accompanying Proxy Statement to the Board of Directors for the ensuing year and until his successor has been elected and qualified, or until his earlier death, resignation or removal;
2.Ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2021;
3.Approve a non-binding advisory resolution relating to the compensation of our named executive officers;
4.Approve a non-binding advisory resolution on the frequency of stockholder votes (every one, two or three years) relating to the compensation of our named executive officers;
5.Transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2019-08-28 |
股东大会：
将于2019-10-16召开股东大会
会议内容 ▼▲
- 1.Elect the seven Board of Director nominees named in the accompanying Proxy Statement to the Board of Directors for the ensuing year and until his successor has been elected and qualified, or until his earlier death, resignation or removal;
2.Ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2020;
3.Approve a non-binding advisory resolution relating to the compensation of our named executive officers;
4.Approve a non-binding advisory resolution on the frequency of stockholder votes (every one, two or three years) relating to the compensation of our named executive officers;
5.Transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2018-08-28 |
股东大会：
将于2018-10-16召开股东大会
会议内容 ▼▲
- 1.Elect the seven Board of Director nominees named in the accompanying Proxy Statement to the Board of Directors for the ensuing year and until his successor has been elected and qualified, or until his earlier death, resignation or removal;
2.Ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2019;
3.Approve a non-binding advisory resolution relating to the compensation of our named executive officers;
4.Transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2017-08-31 |
股东大会：
将于2017-10-16召开股东大会
会议内容 ▼▲
- 1.Elect the seven Board of Director nominees named in the accompanying Proxy Statement to the Board of Directors for the ensuing year and until his successor has been elected and qualified, or until his earlier death, resignation or removal;
2.Ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2018;
3.Approve a non-binding advisory resolution relating to the compensation of our named executive officers;
4.Transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2016-08-25 |
股东大会：
将于2016-10-13召开股东大会
会议内容 ▼▲
- 1.Elect the seven Board of Director nominees named in the accompanying Proxy Statement to the Board of Directors for the ensuing year and until his successor has been elected and qualified, or until his earlier death, resignation or removal;
2.Ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2017;
3.Approve a non-binding advisory resolution relating to the compensation of our named executive officers;
4.Transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|
| 2015-08-28 |
股东大会：
将于2015-10-13召开股东大会
会议内容 ▼▲
- 1.Elect the six Board of Director nominees named in the accompanying proxy statement to the Board of Directors for the ensuing year and until his or her successor has been elected and qualified, or until his or her earlier death, resignation or removal;
2.Ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2015;
3.Approve a non-binding advisory resolution relating to the compensation of our named executive officers;
4.Transact such other business as may properly come before the meeting or any adjournments or postponements thereof.
|